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Involvement of the specific nucleolar protein SURF6 in regulation of 
proliferation and ribosome biogenesis in mouse NIH/3T3 fibroblasts 
 
The nucleolar proteins which link cell proliferation to ribosome biogenesis are 
regarded to be potentially oncogenic. Here, in order to examine the involvement 
of an evolutionary conserved nucleolar protein SURF6/Rrp14 in proliferation of 
mammalian cells, we established stably transfected mouse NIH/3T3 fibroblasts 
capable of conditional overexpression of the protein. Cell proliferation was 
monitored in real-time, and various cell cycle parameters were quantified based 
on flow cytometry, Br-dU-labeling and conventional microscopy data. We show 
that overexpression of SURF6 accelerates cell proliferation and promotes 
transition through all cell cycle phases. The most prominent SURF6 pro-
proliferative effects include a significant reduction of the population doubling 
time, from 19.8±0.7 to 16.2±0.5 hours (t-test, p<0.001), and of the length of cell 
division cycle, from 17.6±0.6 to 14.0±0.4 hours (t-test, p<0.001). The later was 
due to the shortening of all cell cycle phases but the length of G1 period was 
reduced most, from 5.7 ±0.4 to 3.8 ±0.3 hours, or by ~30%, (t-test, p<0.05). By 
Northern blots and qRT-PCR, we further showed that the acceleration of cell 
proliferation was concomitant with an accumulation of rRNA species along both 
ribosomal subunit maturation pathways. It is evident, therefore, that like the yeast 
homologue Rrp14, mammalian SURF6 is involved in various steps of rRNA 
processing. We also concluded that SURF6 is a novel positive regulator of 
proliferation and G1/S transition in mammals, implicating that SURF6 is a 
potential oncogenic protein, which can be further studied as a putative target in 
anti-cancer therapy. 
Key words: nucleolus, SURF6, cell cycle, proliferation, ribosome biogenesis, 
rRNA processing, mouse NIH/3T3 fibroblasts 
 
Introduction 
Ribosome biogenesis is a complex, time-ordered and energy-consuming process that 
occurs mainly in the nucleolus. In nucleoli of mammalian cells, rRNA genes are 
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transcribed to yield the primary 47S pre-rRNA transcripts, which then undergo 
numerous cleavage reactions, post-transcriptional modifications and interactions with 
appropriate proteins to provide a cell with the required number of 18S, 5.8S and 28S 
rRNAs and ribosomes.1,2 Ribosome synthesis is strictly coordinated with cell growth 
and proliferation, so that actively dividing cells, including tumor and embryo cells, have 
particularly well developed nucleoli.3 In line with these data, in vitro experiments 
showed that dysregulation of nucleolar proteins either leads to an arrest of cell cycle and 
drives cells to apoptosis or, in opposite, facilitates cell transformation and uncontrolled 
proliferation.4,5  Consequently, identification of the nucleolar proteins involved in cell 
cycle regulation is important not only for elucidating mechanisms which underlay the 
relationship between nucleolar functions and cell cycle control but also towards the 
development of novel therapeutic interventions for cancer treatment.5-9 
 Several auxiliary rDNA transcription regulators and numerous rRNA processing 
factors such as endo- and exoribonucleases, RNA helicases, NTPases and 
methyltransferases are involved in the synthesis and maturation of rRNAs.10,11 Some of 
these factors are multifunctional proteins, which in addition to making ribosomes also 
participate to cell proliferation. Among the later are the abundant nucleolar chaperons 
NPM1 (B23/nucleophosmin) and nucleolin/C23 which promote cell proliferation 
through stimulatory effects on rDNA transcription, ribosome subunit export and DNA 
replication. 12,13  Overexpression of the Bop1 protein, a member of the PeBoW complex 
that is essential for maturation of the large ribosomal subunit, impairs cell proliferation 
by increasing the percentage of abnormal multipolar mitotic figures. 14,15 In addition, 
several nuclear and cytoplasmic proteins with a partial occurrence in nucleoli are also 
linked to proliferative processes. Such proteins include the nuclear proteins CHD7,16 
Las1L,17 DHX33 helicase,18 Sirt6,19  PHF6,20  and NSA221 as well as ribosomal proteins 
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S3a22 and L36a.23 
 SURF6 has been described as a nucleolar protein that belongs to an 
evolutionary conserved protein family, which members are present in fungi, animal and 
plant kingdoms but are absent in bacteria.24 The characteristic feature of the SURF6 
proteins is the presence of a conservative domain positioned in the carboxyl terminus 
that has an average residue identity of 36% between different species and is enriched 
with lysine and arginine residues, which confer its overall basic charge (pI>10).24 In 
mammals, SURF6 is a product of one of the six genes comprising the surfeit gene locus 
and is a typical housekeeping protein that is expressed in various tissues and throughout 
cell cycle in NIH/3T3 fibroblasts.25,26 A particularly high level of SURF6 expression has 
been described in actively proliferating cells, such as embryonic, progenitor and 
hematopoietic stem lineages.27 Interestingly, in mouse spleenocytes activated for 
proliferation in vitro expression of SURF6 begins before that of the PCNA and Ki-67 
proteins, which are the main proliferation markers in normal and cancer cells.28   
 Presently, functions of SURF6 have mainly been studied in budding yeasts, 
where its homologue is named Rrp14/ykl082c.29,30 Rrp14p has been shown to play 
multiple roles in ribosome biogenesis, from synthesis of the primary 35S pre-rRNA 
transcript to assembly of the large and small ribosomal subunits. Additionally, knockout 
of Rrp14p retards the yeast proliferation by causing defects in budding and organization 
of the mitotic spindle. However, specific roles of SURF6 in proliferation and ribosome 
biogenesis in mammals await additional investigation. Based on large-scale cDNA 
transfection screening of colony formation, SURF6 has been identified as a putative 
cancer-related protein in cultured mouse fibroblasts and human cancer cells.31 We have 
also shown that transient knockdown of SURF6 promotes death in mouse fibroblasts.32 
However, the degradation of rRNA known to occur in dead cells 33 did not allow us to 
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examine a direct link between proliferation and ribosome production in SURF6-
depleted cells.  
In this study, in order to clarify the implication of SURF6 in proliferation and 
ribosome biogenesis, we establish a stable sub-line of mouse NIH/3T3 fibroblasts 
(called NIH/3T3-174 fibroblasts) which is capable to overexpress SURF6 in the 
presence of doxycycline. We show that upon appropriate doxycycline concentrations 
induction of SURF6 overexpression has no notable cytotoxicity but significantly 
accelerates proliferation unless the induced fibroblasts reach cell-cell contacts. Like its 
yeast homologue Rrp14, mammalian SURF6 is involved in rRNA processing along 
both ribosomal subunit maturation pathways. Overall, our data demonstrate that 
mammalian SURF6 is an rRNA processing factor, which promotes proliferation and 
accelerates G1/S transition in non-malignant fibroblasts. Our data endorse the 
hypothesis that mammalian SURF6 is a putative oncoprotein.31  
Results 
Phenotype of stably transfected NIH/3T3-174 fibroblasts 
In order to determine the effect of the protein SURF-6 on the proliferation and ribosome 
biogenesis in mammalian cells, we establish a stable sub-line of mouse NIH/3T3 
fibroblasts (called NIH/3T3-174 fibroblasts), which are capable to overexpress SURF6 
in the presence of doxycycline.  In Fig. 1a, the plasmid construct used to obtain stably 
transfected NIH/3T3-174 fibroblasts is shown. On Western blots of control (-Dox) and 
induced (+Dox) cells SURF6 is visible as a major band with an apparent molecular 
mass of 43 kDa that corresponds to the electrophoretic mobility of mouse SURF protein 
25 (Fig. 1b). After 24 hours of 100 ng/ml doxycycline administration, the amount of 
SURF6 becomes about three times and after 48 hours - up to10 times higher than in  
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-Dox cells. A weaker and more mobile band present in SURF6-overexpressing cells 
results most probably from a partial degradation of the protein. According to qRT-PCR 
results obtained in different experiments, the number of SURF6 mRNA copies 
increased from 2.5-3 (at 24 hrs of post-induction) to 6-8 (at 48 hrs) times (data not 
shown). 
 In Fig. 1c-f, representative microscopic images of NIH/3T3-174 fibroblasts 
incubated without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 48 hours are 
shown. The control (-Dox) fibroblasts (Fig. 1c, d) are almost EGFP-negative (Fig. 1c), 
whereas the majority of +Dox cells (Fig. 1e, f) are brightly fluorescent (Fig. 1e). Like in 
non-transfected cells, 25,26 in +Dox NIH/3T3-174 fibroblasts, SURF6 distributes mainly 
within nucleoli (Fig. 1g). It is worth mentioning that in cells with a stronger EGFP 
fluorescence, nucleoli are more intensely stained for SURF6 than the nucleoli in weakly 
EGFP-fluorescent cells (Fig. 1g, h, asterisks). There  were no visible changes in large-
scale chromatin configuration upon SURF6 overexpression (Fig. 1i). We also did not 
observe significant difference in the number of  dead cells in -Dox and +Dox cell 
populations  neither by conventional microscopy (Fig. 1f) nor by the trypan blue 
excision test (Fig. 3j). These data support a conclusion that excess of SURF6 does not 
cause significant cytotoxic effects at least within 24-48 hours of the induction.  
Effects of SURF6 overexpression on cell proliferation 
 First, we examined effects of the SURF6 excess on cell proliferation in real time 
using the xCELLigence (RTCA)-DP system. Experiments were repeated several times, 
and the results of a representative one are shown Fig. 2a, b. The proliferation rate  of 
NIH/3T3-174 fibroblasts was monitored in the presence of 10 ng/ml, 100 ng/ml or 1000 
ng/ml doxycycline simultaneously with that of non-induced (-Dox) cells (Fig. 2a). In 
Fig. 2b, there are bar graphs illustrating the results of quantification of the curve slopes 
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between 24 hours (the time-point of the doxycycline administration) and ~70 hours (the 
experiment terminus). Both images demonstrate that 1000 ng/ml doxycycline appeared 
to suppress an increase of the cell number. On the contrary, 10 ng/ml and 100 ng/ml 
doxycycline start to promote cell proliferation shortly (~5-6 hrs) after the induction. The 
stimulating effects were intensified with time so that after 24-30 hours of the treatment 
the differences between the normalized cell indexes in the induced and control cells 
became significant (p<0.05; Fig. 2a, b). Therefore, we concluded that induction of 
SURF6 overexpression observed in the presence of both doxycycline concentrations 
(i.e., 10 ng/ml and 100 ng/ml) confers fibroblasts with a proliferative advantage. Taking 
into account that doxycycline can be instable in neutral aqueous solutions, including 
culture medium, the antibiotic concentration of 100 ng/ml was used in all further 
experiments. 
We then examined the proliferation rate of +Dox and –Dox NIH/3T3-174 
fibroblasts by monitoring their number over time with conventional phase contrast 
microscopy and the MTT assay. For the microscopy, fibroblasts were seeded in Petri 
dishes, and cultured for 3 hours to ensure cell attachment to substrate (the T0 time-
point; Fig. 3a). Twenty-five randomly selected fields of view were photographed shortly 
after and then after 24 and 48 hours cell culturing in the absence (Fig. 3b, d, -Dox) or 
the presence (Fig. 3c, e, +Dox) of doxycycline. The cell number per frame was counted 
at every time-point in five independent experiments, averaged, and is presented as the 
mean ± SEM in Fig. 3f. The Figure shows that after the induction, the number of +Dox 
cells/square unit exceeds that in -Dox cells, thereby indicating that the induced cells 
grow faster than the untreated controls. After 24 hours, the differences between the  
-Dox and +Dox values are significant (p<0.05). Similar results were also obtained with 
the MTT assay that measures cell proliferation and viability. Thus, after 24 hours of the 
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induction the number of viable cells in +Dox samples significantly (p<0.05) exceeded 
that in –Dox cells (Fig. 3g, h). Thus, three independent approaches, namely the 
xCELLigence analysis of cells in real time, conventional microscopy and the MTT 
assay showed that incubation of NIH/3T3-174 fibroblasts with 100 ng/ml doxycycline 
stimulated cell proliferation, and that this effect was particularly prominent after ~24 
hours of the induction of SURF6 overexpression.  
Calculation of the population doubling time 
Taking into account the data mentioned above, we calculated the population doubling 
time at 24 and 48 hours of post-induction as described in Materials and Methods (see 
the formula No1).  The results are summarized in Table 1. They show that after the first 
24 hours the doubling time was 16.2±0.5 hours in +Dox NIH/3T3-174 fibroblasts and 
19.8±0.7 hours in the –Dox fibroblasts, or diminished by ~ 20% (t-test, p<0.05). At 48 
hours, the doubling time was equal to 26.6±1.5 hours in +Dox NIH/3T3-174 fibroblasts 
and 21.9±1.9 hours in the –Dox fibroblasts, however, these differences turned out to be 
statistically insignificant (p>0.05).  
 In our cell model, doxycycline increased the level of SURF6 together with 
induction of expression of EGFP (Fig. 1a, c), that is a protein which can be toxic for 
cultured mammalian cells.34,35 To determine whether EGFP affects proliferation in 
NIH/3T3 fibroblasts, we used stably transfected NIH/3T3-EGFP cells, which in the 
presence of doxycycline expressed EGFP alone. As an additional control, non-
transfected (parental) NIH/3T3 fibroblasts were also used. The cells were cultured with 
or without 100 ng/ml doxycycline for 24 and 48 hours. The results obtained are 
included in Table 1. They show that the population doubling time (~18-19 hrs) in all 
control cells (i.e., +Dox and -Dox NIH/3T3-EGFP and parental NIH/3T3 fibroblasts) is 
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similar to that of NIH/3T3-174 cells grown without doxycycline (19.8±0.7 hrs).  
According to the t-test, in these cells the differences in population doubling time was 
not significant (p>0.05). We concluded therefore that in our cell system expression of 
EGFP itself did not statistically significantly influence proliferation of NIH/3T3-174 
fibroblasts at least within 24 hours of the induction, and that the diminution of the 
population doubling time observed in +Dox NIH/3T3-174 cells was due to the 
increasing level of SURF6 but not to the expression of EGFP. At the 48 hours time-
point the population doubling time was 23.3±5.4 in +Dox cells, 31.7±2.5 hours in -Dox 
cells and 24.2±5.5 hours in parental NIH/3T3 fibroblasts. These values did not differ 
significantly (p>0.05) because of essential variation (SEM) between cells in all these 
populations. Thus, in our experimental system the proliferation rate of +Dox and -Dox 
cells differed statistically significant (p<0.05) after one day the induction of SURF6 
overexpression, i.e. when fibroblasts were not in the confluent state and their 
proliferation were not suppressed by contact inhibition  (Fig. 2b, c). Taking into account 
these observations, particular cell cycle parameters in +Dox and -Dox NIH/3T3-174 
cells were determined in at the 24 hour time-point. 
Flow cytometry and timing of cell cycle phases 
To calculate duration of individual cell cycle phases, we used fluorescence activated 
flow cytometry. The results of four independent experiments are shown in Fig. 4, where 
(a) and (b) illustrate one representative experiment, and the panel (c) are the bar graphs 
illustrating the average number of cells at G0/G1, S and G2/mitosis (G2/M) phases 
which were calculated taking into account  all experimental data. SURF6 
overexpression decreases the percentage of cells in G0/G1 phases and simultaneously 
increases the number of S phase cells. The percentage of G2/M cells do not change 
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notably. These data indicate that an excess of SURF6 affects mainly the number of 
G0/G1 and S cells (Fig. 3c).  
The flow cytometry data were then used to calculate the duration of cell cycle 
phases according to the formulae No2-5 (see Materials and Methods for detail). The 
results are summarized in Table 2. The Table shows that in +Dox cells, the cell cycle 
length (14.0±0.4 hrs) was essentially less (t-test, p<0.001) than in –Dox cells (17.6±0.6 
hrs), or was reduced by ~ 25%. The cell cycle was shortened due to the shortening of all 
its phases but only G1 phase was reduced significantly (p<0.05) from 5.7±0.4 hours in –
Dox cells to 3.8±0.3 hours in +Dox cells. The durations of S and G2/mitosis phases 
decreased slightly and insignificantly (p>0.05) (Table 2). 
 We also noticed that overexpression of SURF6 increased the mitotic index from 
4.4±0.4% in -Dox cells to 5.7±1.3% in +Dox cells, but these values did not differ 
significantly (p>0.05).  
Putative mechanisms of SURF6 pro-proliferative effects  
Like in normal cells,25,26 in +Dox NIH/3T3-174 fibroblasts SURF6 is located in nucleoli 
(Fig. 1g). Considering this, we decided to examine whether SURF6 pro-proliferating 
effects are linked to ribosome biogenesis. To reach the aim, RNA was isolated from 
fibroblasts cultured without or with 100 ng/ml doxycycline for 24 hours, and then 
analyzed by Northern blots with [32P]-labeled probes targeting the 18S rRNA or ITS2 
regions of the 47S pre-rRNA transcript. In Figure 5, the map of the 47S pre-rRNA (a) 
and representative blots obtained two independent experiment (b, c) are shown. Fig. 5e  
illustrates the average coefficients (black columns) calculated by normalization of the 
intensity values of each hybridization band observed +Dox cells to the corresponding 
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values in -Dox cells, which are considered as equal to 1 (grey columns).   The 
coefficients were calculated based on the results of several experiments. SURF6 
overexpression noticeably  increases the amount of all analyzed rRNA intermediates 
except for 36S rRNA (Fig. 5e) that is the longest common precursor for 5.8S and 28S 
rRNAs (Fig. 5d). The most prominent changes concern accumulation of 45S pre-rRNA 
(a common precursor for 18S, 5.8S and 28S rRNA formed downstream from 47S pre-
rRNA), 34S and 20S rRNAs (the precursors for 18S rRNA) and of 32S rRNA that is 
formed along the 28S rRNA maturation pathway downstream from 36S rRNA (Fig. 5d, 
e).  
 The data of qRT-PCR analysis of the PCR-products (amplicons) corresponding 
to the 5’ETS, 18S, 5.8S and 28S rRNA sequences (Fig. 5a) after 24 hours of the 
induction are shown in Fig. 5f. The black columns are the mean of fold change values 
(N) determined in +Dox cells and normalized to the mean values in –Dox controls in 
four independent experiments.  Overexpression of SURF6 increases the number of all 
amplicons up to two times. A higher number of the amplicons corresponding to the 
short-lived 47S pre-rRNA (detected with the 5’ETS probe) favors the assumption that 
an enhanced level of SURF6 stimulates rDNA transcription. An increased level of other 
detected amplicons, in the whole, corresponds to the Northern blot data favoring an 
accumulation of the rRNA intermediates upon SURF6 overexpression. 
Discussion 
SURF6 and cell proliferation 
Presently, a loss-of-function (knockdown) approach is routinely used to examine a 
putative involvement of nucleolar proteins in cell cycle control. Based on this approach, 
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the main nucleolar rRNA processing factors NPM1/B23/nucleophosmin,36 
nucleolin/C23 13 and nucleostemin 37,38 have been recognized as positive regulators of 
cell proliferation in various cells. Similarly, we applied a loss-of-function approach for 
studying SURF6 in transiently transfected NIH/3T3 fibroblasts and showed that 
knockdown of SURF6 affected cell cycle progression.32 However, the loss-of-function 
approaches are usually limited for drawing fine conclusions on the link between 
proliferation and ribosome biogenesis by nucleolar proteins, such as SURF6, as these 
proteins are vital and their knockdown causes cell death and rRNA degradation.33 
Consequently, a conditional gain-of-function (overexpression) approach can be more 
appropriate in cell proliferation studies. 
 Data illustrating a capability of nucleolar proteins to accelerate proliferation 
upon inducible expression remain strikingly scarce. To the best of our knowledge, only 
the NPM1 protein,39  a nuclear protein with a partial nucleolar occurrence 
NSA2/TINP1,21 and ribosomal proteins RPL36a 23 and RPS3a 22 have been shown to be 
involved in proliferation by gain-of-function approaches. Experimentally induced 
overexpression of NSA2 (the Nop seven-associated 2 protein) facilitates transition of 
G1 phase to S phase in human cancer cells. NPM1, RPL36a and RPS3a stimulate 
transformation of normal NIH/3T3 fibroblasts by promoting colony formation and 
anchorage-independent growth in vitro and contribute to tumorgenesis in vivo. 
However, mechanisms of these phenomena have not been examined. Conditional 
overexpression of many other nucleolar proteins either suppresses proliferation (e.g., 
nucleostemin,37 PAK1IP1,40 Bop1 14 or does not exert notable effects (WDR12, Pes1 14).  
Here, by using stably transfected NIH/3T3-174 fibroblasts capable of 
conditional overexpression of SURF6 and by several independent approaches, i.e. 
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monitoring cell proliferation in real time with the xCELLigence system, flow 
cytometry, and conventional phase-contrast microscopy, we have found that 
overexpression of SURF6 can promote  proliferation of normal mammalian cells. In 
sub-confluent NIH/3T3-174 fibroblasts, overexpression of SURF6 diminishes the 
population doubling time (by ~20%, p<0.001), the duration of cell division cycle (by 
~25%, p<0.001), and specifically shortens G1 phase (by ~30%, p<0.05) as compared 
with the non-induced cells (Tables 1 and 2). Moreover, calculations of the duration of 
cell cycle phases showed that SURF6 is unlikely to control S phase rather to be 
involved in the G1/S transition (Table 2). Thus, our results indicate that the nucleolar 
protein SURF6 plays a role in cell proliferation control as a positive regulator of G1/S 
transition in non-malignant cells.  
Importantly, the SURF6 pro-proliferating effects could be manifested only upon certain 
experimental conditions. Specifically, 1000 ng/ml doxycycline, the dose recommended 
for the Tet-On system in mammalian cells,41 appeared to be toxic in NIH/3T3-174 
fibroblasts (Fig. 2a, b). An optimal doxycycline concentration, 100 ng/ml, significantly 
activated proliferation in sub-confluent fibroblasts but became less effective, when the 
cells reached confluency. Thus, after 48 hours of the induction, when a monolayer 
became nearly complete (Fig. 3d, e), the cell proliferation doubling-time in +Dox cells 
(26.6±1.5 hours) exceeds that in -Dox cells (21.9±1.9 hours) despite differences 
between the values are insignificant (p>0.05)  (Table 1). Taking into account that 
proliferation of mouse 3T3 fibroblasts is inhibited when they reach confluence 50 and 
that in HeLa cells SURF6 interacts with the specific RNA polymerase I cofactor UBF,42 
which is suppressed in steady-state fibroblasts,43 one could assume that SURF6 pro-
proliferation activity may be mediated by contact inhibition and recruits UBF.  
SURF6 and ribosome biogenesis  
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The yeast homologue of SURF6, the Rrp14 protein, functions in ribosome biogenesis as 
a regulatory factor required for maturation of both ribosomal subunits. In addition, in 
Rrp14p-depleted cells 35S pre-rRNA synthesis appeared to decline.29,30 However, 
ribosome biogenesis steps, which recruit SURF6 in mammalian cells, remain undefined. 
Here we show that in mouse fibroblasts conditional overexpression of SURF6 affects 
various steps of rRNA processing. Based on the Northern blot data, SURF6 
overexpression causes accumulation of 34S and 20S rRNAs (the precursors for 18S 
rRNA) and of 32S rRNA that is a precursor for 28S rRNA (Fig. 5b-e). Nonetheless, we 
did not observe an accumulation of the longest common precursor for 5.8S and 28S 
rRNAs, the 36S rRNA (Fig. 5b-e). Considering this, it is tempting to speculate that 
SURF6 is involved in the cleavage of 36S rRNA along the ITS2 spacer (Fig. 5d). 
Northern blots also showed that an excess of SURF6 causes an accumulation of 45S 
pre-rRNA (Fig. 5b-e) that is formed downstream from the 47S pre-rRNA precursor 
(Fig. 5d). This may result either from retardation of 45S pre-rRNA processing or from 
activation of the 47S pre-rRNA synthesis. The later assumption sounds more probable 
because the number of amplicons corresponding to the shortly lived 5’ETS fragments 
determined by qRT-PCR points to a 1.5-fold increase of the 47S pre-rRNA copies in 
+Dox fibroblasts as compared with –Dox cells (Fig. 5f). The increase of 18S, 5.8S and 
28S rRNA amplicons also detected by qRT-PCR (Fig. 5f) is consistent with the 
Northern blot data, evidencing in favor that SURF6 is involved in the maturation of 
both subunits at the point of rRNA processing. (Fig. 5b-e). In addition, the accumulation 
of these amplicons may arise from an increasing level of the cytoplasmic rRNAs, which 
were not specifically identified on the blots. 
Overall, our work concludes that the nucleolar protein SURF6 is involved in the 
maturation of both ribosomal subunits at the point of rRNA processing. Undoubtedly, 
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SURF6 can stimulate proliferation of sub-confluent NIH/3T3-174 fibroblasts by 
decreasing their population doubling-time, shortening the cell division cycle and by 
facilitating G1/S transition, and thereby serves as a positive regulator of proliferation in 
non-malignant mammalian cells. Our results endorse the assumptions that SURF6 could 
be a putative oncoprotein 31 and an appropriate candidate for anti-cancer therapy.44 
Material and methods 
Cells and DNA plasmid constructs 
Mouse embryo NIH/3T3 fibroblasts were purchased from the Russian Collection of Cell 
Cultures (Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russia). 
Cells were grown in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, USA) 
supplemented with 10% fetal calf serum (FCS; HyClone, USA), 4.5 g/L glucose, 2 mM 
L-glutamine, 1.5 g/L sodium bicarbonate, penicillin, and streptomycin (100 units/ml 
each) at 37° C and the atmosphere of 5% CO2/95% air. 
Stably transfected NIH/3T3-174 fibroblasts were established by the use of two 
plasmid constructs, which are components of the Tet-On® gene expression system 
(Clontech Laboratories, Inc., USA). The first (auxiliary) plasmid pcDNA3.1(-)rtTA 
encodes the tetracycline-controlled transactivator and the neomycin (G418) resistance 
gene. It was created by cloning the reverse transcriptional transactivator (rtTA) cDNA 
from the pUHrT62-1 plasmid 45 into the EcoRI/BamHI cloning sites of the pcDNA3.1(-) 
vector (Invitrogen, USA). The second (executive) plasmid, named as pBI-mSURF6, 
was engineered using a commercial vector pBI-EGFP (Clontech Laboratories, Inc.). 
The NheI/NheI 1.9 kb cDNA fragment, corresponding to the mouse SURF6 coding 
region, was cut off from the pBS-Surf6 clone 25 and re-cloned to the NheI cloning sites 
of the pBI-EGFP vector. The resulted pBI-mSURF6 plasmid contains a bi-directorial 
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TRE (tetracycline-responsible element) activated by the rtTA expression product 
flanked by two minimal bi-directorial CMV promoters which govern co-expression of 
SURF6 and EGFP (Fig. 1a).  
Transfections were performed with the Lipofectamine2000 reagent (Invitrogen, 
USA). NIH/3T3 fibroblasts were transfected with the pcDNA3.1(-)rtTA plasmid, and 
the transfectants were selected by one-month culturing in the presence of 450 µg/ml 
G418. Selected clones were co-transfected with the plasmid pBI-mSURF6 (to generate 
NIH/3T3-174 fibroblasts) or with the pBI-EGFP vector (to generate NIH/3T3-GFP cells 
capable to express EGFP alone) mixed in the equal amounts with a linear DNA 
fragment containing the puromycin-resistance gene. The DNA fragment of the 
puromycin-resistance gene was excised from the plasmid pLoxPuro with BamHI.46 The 
transfectants were cultured in complete DMEM supplemented with 200 µg/ml G418 
and 1 µg/ml puromycin for another month. Clones resistant to the second selection were 
transferred to wells of a 96-well plate and allowed growing. Most healthy clones were 
named as NIH/3T3-174 and NIH/3T3-GFP fibroblasts and used in the study. 
The stably transfected cells were cultured in DMEM medium containing 10% 
Tet-On approved fetal bovine serum (FBS, Clontech Laboratories, Inc.), 4.5 g/l glucose, 
2 mM L-glutamine, 1.5 g/l sodium bicarbonate, penicillin  and streptomycin (100 
units/ml each), 200 µg/ml G418  and 0.5 µg/ml puromycin at 37° C and in the 
atmosphere of 5% CO2/95%. Cells were plated with initial density of 3-5×103 cell/сm2 
unless indicated otherwise. Doxycycline chloride (Sigma-Aldrich, USA) was dissolved 
in DMEM to the final concentrations 10, 100 or 1000 ng/ml and added to sub-confluent 
cells cultured in complete growth medium for 3-24 hours prior the induction. In control 
experiments (-Dox, non-induced cells), the equal volume of DMEM alone was added. 
The initial cell density was counted with an automated cell counter Cedex XS Analyzer 
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(Roche, USA). 
Immunoblotting and immunofluorescence 
For immunoblots, 5×106  cells were lysed in 500 µl buffer containing 50 mM Tris-Cl, 
pH 7.5, 150 mM NaCl, 10% glycerol, 0.5% Triton X-100 and a cocktail of protease 
inhibitors (Sigma-Aldrich) on ice. The total protein concentration in samples was 
determined with the Lowry-Peterson assay using a Protein Assay Kit (Sigma-Aldrich). 
Fifty µg of proteins in Laemmli buffer (60 mМ Tris-Cl, рН 6.8, 10% glycerol, 2% SDS, 
100 mM β-mercaptoethanol, 0.01% bromophenol blue) was loaded in every lane of 
12% SDS-PAGE. Blotted  nitrocellulose membranes were incubated with the rabbit 
serum specifically recognizing mouse SURF6 26 or with a mouse monoclonal antibody 
to beta-tubulin (Sigma-Aldrich) served as a loading control, and then with relevant 
horseradish peroxidase–conjugated antibodies diluted in TBST buffer (20 mМ Трис, 
рН 7.6, 150 mМ NaCl, 0.05% Tween-20) supplemented with 5% skim milk. The 
proteins were recovered using an ECL+Plus Kit (Amersham Pharmacia Biotech Inc., 
USA). Quantification of the immunoblot signals was performed with TotalLab 
Quantification Software (TotalLab Limited, UK). 
 For immunofluorescence, NIH/3T3-174 fibroblasts grown on coverslips were 
fixed with 2% paraformaldehyde in phosphate buffered saline (PBS, 140 mM NaCl, 2.7 
mM KCl, 1.5 mM KH2PO4, and 8.1 mM Na2HPO4, рН 7.2) for 20 min at room 
temperature. Then, they were treated with 0.5% Triton X-100 in PBS for 10 min at 
room temperature, and labeled with the anti-SURF6 serum 26 followed by AlexaFluor 
488 goat anti-rabbit IgG (H+L) (Molecular Probes Inc., USA, cat.A-11034). Cells were 
counterstained with a DNA-binding dye DAPI (1 μg/ml in PBS, 10 min), mounted in 
Vectashield® (Vector Laboratories, USA), and examined with a DuoScanMeta 
LSM510 confocal laser scanning microscope (Carl Zeiss, Germany) equipped with a 
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Plan-Apochromat 63×/1.40 (numerical aperture) oil Ph3 objective. 
Analysis of cell growth with the xCELLigence System 
 The xCELLigence Real-Time Cell Analysis (RTCA)-DP system (ACEA 
Biosciences, CAL, USA) was used to monitor cell growth in real time according to.47 
The technology measures impedance-based signals, which occur through cell contacts 
with microelectrodes, and the signal values are interpreted as normalized cell indexes. 
NIH3T3-174 cells were seeded in duplicate in an E-16 plate (ACEA Biosciences), 
cultured under standard conditions for ~24 hours before adding 10-1000 ng/ml 
doxycycline in DMEM or DMEM alone (the –Dox controls). Impedimetric signals were 
recorded automatically every 15 min for ~3 days. The cell growth rate was determined 
by calculating the slope of the curves between the time-point of doxycycline 
administration (~24 hrs) and the time-point corresponding to the end of an experiment 
(~70 hrs). Experiments were repeated several times, and the results are expressed as the 
mean ± SEM (Standard Error Mean).  
MTT assay 
NIH/3T3-174 fibroblasts were seeded in 24-well plates in complete growth medium for 
3 hours to be recovered. Cells were rinsed three times with PBS and incubated in 
serum-free medium for 24 hours, and afterwards 100 ng/ml doxycycline in DMEM 
(+Dox cells) or the equal volume of DMEM (-Dox cells) were added as described.48 
The MTT assay was executed as recommended by the manufacture (Life Technologies, 
France) shortly after doxycycline administration (“0” time-point) and also 24 and 48 
hours later. Absorbance was read at 540 nm with a Thermo Scientific Multiskan EX 
ELISA reader (Thermo Fisher Scientific, USA). Experiments were repeated in 
triplicate. 
Calculation of the population doubling time 
19 
 
Cells were seeded in 6 cm Petri dishes and after culturing for 3-4 hours, 100 ng/ml 
doxycycline in DMEM or DMEM alone (-Dox control) were added (time-point “0”, 
T0). Twenty five random fields of view were photographed at the “0” point and then 
every 24 hours (Tt) under a microscope Axiovert 200 (Carl Zeiss, Germany) coupled 
with a 8-bit digital CCD camera CoolSnapcf (Photometrics, USA) and a Plan-Neofluar 
10×/NA0.4 Ph lens. The average cell population doubling time (td) was calculated with 
the formula (No1):  
 td = t/log2 (Nt/N0) (1) 
where t is an interval (in hours) between T0 and Tt, and N0 and Nt are the average cell 
number per microscopic field of view at the same time-points.49 Experiments were 
repeated five times.  
Flow cytometry 
Cells were fixed with 70% ethanol for 15 min at 4о С and stained with 50 µg/ml 
propidium iodide (Sigma-Aldrich) in PBS containing 0.5 mg/ml bovine pancreatic 
RNAase A (Sigma-Aldrich) for 1 h at 37о С. Above 1×104 cells were analyzed in each 
sample using a flow cytometer Epics ”Elite” (Beckman Coulter Inc., USA) equipped 
with an argon laser Cyonics (Uniphase, USA) and Multigraph software (Coulter, USA). 
Experiments were repeated four times. 
Timing of cell cycle and the cell cycle phases 
The duration of the cell division cycle (T, hours) was calculated according to 49 with the 
equation (No2):  
 T = td/log2 [(2 – y)/(1 – y)] (2)  
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where td – the average cell population doubling time, and y - the average percentage of 
G0 cells (G0 index). 
To determine the G0 index, cells were seeded on coverslips, cultured overnight 
and incubated with 10 mМ Br-dU (-Dox control cells) or 10 mМ Br-dU + 100 ng/ml 
doxycycline (+Dox cells) for 24 hours, a period that exceeds the division cycle in 3T3 
fibroblasts.50 The cells were fixed with 4 % paraformaldehyde in PBS for 20 min, 
permeabilized with 0.5% Triton Х-100 in PBS for 10 min, and treated with 2М HCl for 
40 min at room temperature. Cells were intensely washed in PBS, immersed in a mouse 
anti-Br-dU monoclonal antibody (Roche, USA) for 45 min and then to Texas Red-
conjugated antibodies to mouse IgG (Jackson ImmunoResearch Labs, Inc., USA) for 45 
min at 37о С. Cells were counterstained with DAPI (4',6-Diamidino-2-phenylindole 
dihydrochloride) and mounted in Vectashield® (Vector Laboratories, USA). Samples 
were examined under an Axiovert200 epifluorescence microscope equipped with a 
Plan-NeoFluar ×40/NA 0.75 Ph lens. Br-dU-negative cells were considered as G0, or 
steady-state, cells. Above 2,000 cells were analyzed at each experimental and control 
time-points. G0 index was defined as the ratio between the number of G0 cells to the 
total number of cells. The sum duration of G2 phase and mitosis (tG2+M, hours) was 
calculated with the formula (No3) 51 : 
  tG2+M= T×log2(((G2+M)/N)/y'+1)  (3)  
where (G2+M)/N – the percentage of cells in G2 phase and mitosis, y' – the percentage 
of proliferating cells equals to the total number of cells minus G0 cells. The percentage 
of G2 and mitotic cells, i.e., G2/M cells, was determined by flow cytometry.  
 The length of S phase (ts, hours) was calculated with the equation (No4) 51 :  
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 ts=T×log2((S/N)/((G2+M)/N+y')+1) (4) 
 where T – the duration of cell cycle in hours, S/N – the percentage of S phase cells, 
(G2+M)/N – the percentage of G2+mitotic cells, y' – the percentage of proliferating 
cells. The percentage of S phase cells was determined by flow cytometry.  
 The length of G1 phase (tG1, hours) was calculated with the formula (No5) 51:  
    tG1 = T – (tS+tG2+M)     (5)  
where T is the durations of cell division cycle, tS is the duration of S phase, and tG2+M is 
the sum duration of G2 phase and mitosis determined according to the formula (3). 
Mitotic index, or the ratio between the number of mitotic cells and the total 
number of cells, was counted using DAPI-stained cells, a microscope Axiovert 200 and 
a Plan-NeoFluar ×40/NA 0.75 Ph lens. Above 2,000 cells were analyzed at each control 
and experimental point.  
Northern blot analysis 
Approximately 1×106 cells were lysed with 1 ml TRIzol® Reagent (Life Technologies, 
USA) and RNA was isolated as recommended by the manufacture and then quantified 
with a nanodrop spectrophotometer (Thermo-Scientific).  In all samples, the ratio 
А260/А280 was within the range of 1.9 to 2.0 thus indicating the absence of protein 
impurities.  RNA was processed for Northern blotting as described previously.52 Five 
micrograms of total RNAs were fractionated on standard 1% agarose/6%  formaldehyde  
gels  to  analyse  RNA  species. Fifty pmol of a probe was mixed with 50 pmol of [γ-
32P]ATP and T4 polynucleotide kinase (Promega, France) and incubated for 30 min at 
37° C. For each experimental condition, the radioactivity contained in each band was 
quantified with a PhosphorImager (Typhoon, GE Healthcare, USA). Two independent  
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experiments were performed. The values obtained in +Dox NIH/3T3-174 fibroblasts 
(100 ng/ml doxycycline, 24 hrs of the treatment) were averaged on the basis of four 
Northern blot data and expressed as the mean values normalized to the control mean 
values obtained in –Dox fibroblasts. Statistical analysis (one sample t-test) from results 
obtained in independent experiments was performed with RStudio software 
(https://www.rstudio.com/products/rstudio/)  . 
Quantitative reverse transcription PCR (qRT-PCR) 
Total RNA was isolated from –Dox and +Dox fibroblast after 24 hours of 100 ng/ml 
doxycycline administration and used to determine expression of rRNA species as 
described in.53 The primers and FAM-conjugated probes targeting the short-lived 5’ETS 
and the 18S, 5.8S and 28S regions of the mouse 47S pre-rRNA (GenBank ID: X82564), 
Surf6 mRNA (GenBank ID: NM_009298) and beta-actin mRNA (GenBank ID: 
NM_007393) were designed with AlleleID 7.7 software (Premier Biosoft, USA) and 
synthesized by DNA-Synthesis LLC (Moscow, Russia) (Table 3). Beta-actin mRNA 
served as the internal reference control. The master mix, qPCRmix-HS 
(Evrogen,Moscow, Russia), and 2 μl of cDNA were used in a PCR reaction. qRT-PCR 
was performed five times for each target amplicon (i.e., 5′ETS, 18S, 5.8S and 28S 
rRNA, Surf6 mRNA and beta-actin mRNA) using a MiniOpticon RT-PCR system 
(BioRad, Hercules, USA) with the following parameters: 5 min cDNA denaturation at 
95o C and 40 PCR cycles each for 15 s at 95o C, 20 s at 55o C and 20 s at 72o C. Melting 
curve analysis and gel electrophoresis were used to control the specificity and the 
quality of PCR. The data were analyzed with Bio-Rad CFX software (BioRad). Fold-
induction values (N) were calculated for each target amplicon as described in 54 with the 
formula:  
N=2-ΔΔCt 
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Herein, ΔΔCt represents the difference between ΔCt+dox and ΔCt-dox values for each 
given amplicon, ΔCt is the difference between Cttarget and Ctreference, and Ct is the mean 
threshold cycle for each target and the reference amplicons. The results of five qRT-
PCR independent experiments were averaged. 
Statistical analysis 
 Results are expressed as mean ± standard error of the mean (SEM). Control and 
experimental values were compared with the Student t-test assuming unequal variances.  
Differences are considered significant at a p value less than 0.05. Microsoft  Excel 2007 
software (Microsoft, Redmond , WA,USA) was used for statistical analysis of data. 
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Figure legends  
Figure 1. (a) A diagram of the pBI-SURF6 plasmid used for generation of stably 
transfected mouse NIH/3T3-174 fibroblasts capable to overexpress SURF6 in the 
presence of doxycycline (Dox). ampR – ampicillin-resistence gene, EGFP – the 
sequence coding for the EGFP protein, CMV – minimal CMV promoter, TRE – 
tetracycline-responsive element, SURF6 cDNA – cDNA of the mouse SURF6 gene, 
Surf6. (b) Immunoblots of control and induced NIH/3T3-174 fibroblasts after 
incubation without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 24 and 48 hours. 
SURF6 was revealed with the anti-SURF6 serum,26 β-tubulin (a loading control) was 
recognized with a commercial antibody. Star (*) indicates a position of a faster 
migrating SURF6 form appeared in +Dox fibroblasts. (c-i) General images of NIH/3T3-
174 fibroblasts cultured without (-Dox; c, d) or with (+Dox; e-i) 100 ng/ml doxycycline 
for 48 (c-f) or 24 (g-i) hours. (c, e, h) – EGFP fluorescence, (d, f) – phase contrast, (g) – 
immunolabeling for SURF6; (i) – DAPI staining of chromatin. (j)  
 In the absence of doxycycline, almost no EGFP fluorescence is seen (c). In the 
presence of doxycycline, the cells are intensely marked for EGFP (e, h), hereby 
indicating an effectiveness of the pBI-SURF6 plasmid. The phenotype of +Dox 
fibroblasts (f) remains similar to that of -Dox cells (d). SURF6 is distributed in nucleoli 
(g, arrows). A less intense anti-SURF6 immunolabeling of nucleoli is generally seen in 
cells with a weaker EGFP fluorescence (asterisks, g, h). Large-scale nuclear 
organization looks similar in different cells (i). Scale bars, (c-f) – 100 µm, (g-i) - 30 µm. 
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(j) Trypan blue excision assay. Bar graphs illustrating the number of dead cells in –Dox 
(control, grey columns) and +Dox (black columns) cells after 24 and 48 hours of the 
induction. At each time-point, the control and experimental values do not differ 
statistically significant (p>0.05).  The data are shown as the mean ± SEM (n=3). 
 
Figure 2. Growth rate of NIH/3T3-174 fibroblasts monitored in real time with the 
xCELLigence (RTCA)-DP instrument system. 
(a) Cells (~3,000/well) were seeded in duplicate in an E-16 plate and cultured in the 
absence (-Dox, control) or the presence of 10 ng/ml, 100 ng/ml and 1000 ng/ml (+Dox) 
doxycycline. Doxycycline in DMEM (+Dox) or the equal volume of DMEM alone (-
Dox) were added after 24 hours of cell seeding (arrow). The horizontal axis - time in 
hours from the beginning of the experiment. The vertical axis - the normalized cell 
index automatically registered every 15 min. Small vertical bars in the curves are 
fluctuations of the index at each registration time-point occurred in duplicates.  
 Doxycycline in the concentration of 1000 ng/ml (pink curve) represses cell 
growth, while 10 ng/ml (blue curve) and 100 ng/ml (red curve) doxycycline stimulate 
proliferation as compared with -Dox cells (green curve). The SURF6 pro-proliferative 
effects start to be visible after 5-6 hours of the induction (corresponds to ~30 hrs on the 
horizontal axis) and intensify with time.  
(b) Bar graphs illustrating the mean normalized cell index in +Dox cells in the 
percentage to control (-Dox) values considered as 100%. The proliferation rate was 
determined by analyzing the slopes of each curve obtained between the doxycycline 
administration (at ~24 hrs of post-seeding) and the end of an experiment (~70 hrs of 
post-seeding; n=3). The results are expressed as the mean ± SEM. (*) indicate the 
values which differ insignificantly (p>0.05). 
 Induction of SURF6 overexpression with 10 ng/ml and 100 ng/ml doxycycline 
significantly (p<0.05) activates proliferation as compared with non-stimulated 
NIH/3T3-174 fibroblasts, whereas 1000 ng/ml doxycycline turns out to be cytotoxic for 
the cells.  
 
Figure 3. Effects of SURF6 overexpression on proliferation and viability of NIH/3T3-
174 fibroblasts cultured without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 48 
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hours as analyzed with conventional phase contrast microscopy (a-f) and the MTT assay 
(g, h). 
 (a-f) Cells were seeded in Petri dishes, cultured in complete growth medium for 
3-4 hours to retrieve cell attachment to substrate. Twenty-five random fields of view 
were photographed shortly after doxycycline administration (“0” time-point, a) and 24 
(b, c) and 48 (d, e) hours later, and representative images of the cells are shown in (a-e). 
Experiments were repeated five times, and in (f) bar graphs illustrating the mean cell 
number per field ± SEM are shown. The horizontal axis – time in hours, the vertical 
axis – the number of cells per square unit, small vertical bars – SEM.  
 (g, h) Bar graphs illustrating MTT assay results. The horizontal axes – time in 
hours, the vertical axes in panel (g)  – OD values at 570 nm, in panel (h) – the ODT 
/OD0  ratios equal to  the OD values scored after 24 and 48 hours and normalized to the 
relative OD values at the “0” time-point. The data are presented as the mean ± SEM 
based on the results of three independent experiments.  
 
Figure 4. Effects of SURF6 overexpression on cell cycle progression in NIH/3T3-174 
fibroblasts as examined by flow cytometry after 24 hours of post-induction with 100 
ng/ml doxycycline. (a, b) Results of a representative experiment, where cells were 
cultured without (-Dox, a) or with (+Dox, b) doxycycline. In the panel (с), bar graphs 
illustrate the mean percentage of +Dox (black columns) and -Dox (grey columns) cells 
which was calculated on the basis of four independent experiments. In G0/G1 phase the 
number of +Dox cells (46.2 ± 2.0%) is significantly lower (p<0.05) that the number of -
Dox cells (49.6 ± 1.9%), while in S phase the number of +Dox cells (44.9±2.6%) 
significantly (p<0.05)  exceeds that of -Dox cells (40.5±2.0%). The numbers of +Dox 
and –Dox cells at G2/mitosis are rather similar. Data of four independent experiments 
are presented as the mean ± SEM.  
 
Figure 5. The diagram of the primary 47S pre-rRNA in the mouse (a), Northern blot (b, 
c, e) and qRT-PCR (f) analysis of rRNA expression in NIH/3T3-174 fibroblasts 
cultured without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 24 hours.  
  (a) 5’ETS, the 5’ external transcribed spacer; ITS1 and ITS2, the internal 
transcribed spacers 1 and 2 correspondingly; 18S, 5.8S and 28S are 18S, 5.8S and 28S 
rRNAs correspondingly. Small vertical bars and designations above the schemes 
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indicate positions of the known pre-rRNA cleavage sites. Small horizontal bars above 
the schemes indicate positions of the PCR amplicons for  5′ETS and 18 S, 5.8 S, 28 S 
rRNA (according to 1). 
  (b, c) RNA was isolated from sub-confluent fibroblasts and hybridized with 
[P32] labeled probes recognizing the 18S rRNA (b) or ITS2 (c) regions of the 47S pre-
rRNA transcript (a). Arrows indicate positions of the main rRNA species.  
 (d)  In mouse cells, processing of the 45S pre-rRNA proceeds mainly through 
two alternative pathways. In pathway 1, the pre-rRNA processing is initiated in the 5’-
ETS to yield 41S pre-rRNA, while in pathway 2, the first cleavage occurs in  ITS1 at 
site 2c to yield 34S rRNA (the longest precursor for 18S rRNA) and 36S rRNA (the 
longest precursor for 28S rRNA). The 41S pre-rRNA is further cleaved at site 2c into 
20S and 36S rRNAs, which are then processed to 18S and 28S rRNAs correspondingly. 
(according to 1). 
 (e) Bar graphs illustrating intensities of rRNA hybridization signals in +Dox 
cells (black columns) normalized to the values in -Dox cells (grey columns). Data in 
+Dox cells are presented as the mean ± SEM based on quantification of the results of 
four Northern blots.  
  (f) Bar graphs illustrates the amount of the 47S pre-rRNA (the 5’ETS 
amplicons), 18S, 5.8S and 28S rRNAs in +Dox cells (black columns) normalized to the 
values in -Dox cells (grey columns). The values obtained in +Dox cells are presented as 
the mean N ± SEM based on the results of five independent experiments. 
 





Table 1. Population doubling time (in hours) in different types of NIH/3T3 fibroblasts as calculated with the formula 1 (see Material and 
Methods for detail) after cell culturing without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 24 and 48 hours. The data are expressed as the mean 
± SEM (Standard Error of the Mean). At 24 hours of post-induction, the values observed in –Dox and +Dox NIH/3T3-174 fibroblasts differ 
statistically significantly (t-test, p<0.001) and are shown in bold. The population doubling time in –Dox NIH/3T3-174, -Dox NIH/3T3-EGFP, +Dox 
NIH/3T3-EGFP and parental NIH/3T3 fibroblasts do not differ significantly (p>0.05). At 48 hours,  the population doubling-time between different 
fibroblasts differs insignificantly (p>0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cells 
Cell population 
doubling time  
 
NIH/3T3-174  
(-Dox)  
 
NIH/3T3-174  
(+Dox)  
 
 
NIH/3T3-EGFP   
(-Dox) 
 
 
NIH/3T3-EGFP 
(+Dox) 
 
Parental 
NIH/3T3 
(-Dox) 
24 hours 
 
19.8±0.7 
 
16.2±0.5 
 
 
19.0±0.2   
 
19.6±0.9  
 
18.2±0.2   
48 hours 
 
21.9±1.9 
 
26.6±1.5 
 
23.3±2.5 
 
27.7±5.4 
 
24.2±3.2 
 
Table 2. Duration (in hours) of cell cycle phases in sub-confluent NIH/3T3-174 fibroblasts 
cultured without (-Dox) or with (+Dox) 100 ng/ml doxycycline for 24 hours after seeding. In 
brackets, the formulae used for calculations are indicated (see Materials and Methods for detail). 
The percentage of cells at G0/G1, S and G2/mitosis phases was determined by flow cytometry. 
The percentage of G0 cells was measured by cell population culturing with Br-dU for 24 hours. 
The number of G1 cells was     as the number of G1/G0 cells minus the number of G0 cells. Data 
are expressed as the mean ± SEM. The compared pairs of values, which according to the t-test, 
differ significantly (p<0.05) are indicated in bold. The duration of the cell division cycle in -Dox 
cells (17.6±0.6) and in +Dox cells (14.0±0.4) differ with p<0.001. 
 
Parameters 
 
NIH/3T3-174  
-Dox (control)  
 
NIH/3T3-174  
+Dox  
 
Cell number 
(%) 
Duration  
(hours) 
Cell number 
(%) 
 
Duration 
(hours) 
G0 period 15.0 ±2.4  18.0±3.4  
 
Cell division cycle(2)   17.6±0.6  14.0±0.4  
G1 phase(5) 34.6±1.9 5.7 ±0.4 28.2±2.0 3.8 ±0.3 
S phase(4) 40.5±2.0 9.0 ±0.4 44.9±2.6 8.1 ±0.4 
G2 phase+mitosis(3) 9.9±1.2 2.8 ±0.3 8.9±0.6 2.1 ±0.1 
Table 3. Primers and FAM-conjugated probes used in qRT-PCR analysis of the amplified DNA 
products (amplicons) corresponding to the mouse 47S pre-rRNA transcripts, 18S, 5.8S and 28S 
rRNAs, beta-actin and SURF6 mRNAs. 
 
 
Target region 5’- primers Probes  3’- primers  
5’ETS  
(9-107 nt) 
 
 
18S rRNA 
(4896-5032 nt) 
 
 
5.8S rRNA 
(6881- 6978 nt) 
 
 
28S rRNA 
(12081-12166 nt) 
 
 
beta-actin 
(869-989 bp) 
 
 
SURF6 
(247-343 bp) 
 
АСАCGCTGTCCTTTCC
CTATTA  
 
 
СТАTTTTGTTGGTTTT
CGGAACTG 
 
 
CTCTTAGCGGTGGAT
CACTC 
 
 
TACGAATACAGACCG
TGAAAGС 
 
 
GTAAAGACCTCTATG
CCAАСАС 
 
 
CCAATGGTATCCAAA
CAAGAGAA 
 
CGATTTAAGGCTGTTTTGCT
TGTCCAGCC  
 
 
СТАGAGGTGAAATTCTTGG
ACCGGCG 
 
 
GTGCGTCGATGAAGAACGC
AGСТАGC 
 
 
AAAGGTCAGAAGGATCGTG
AGGCCCC 
 
 
TGTACCCAGGCATTGCTGA
CAGGATG 
 
 
TGTGCCTTGGCTАТСTTTAG
GGGACC 
 
CCCAAGCCAGTAAAAAG
AATAGG 
 
 
TAATGAAAACATTCTTG
GCAAATGCT 
 
 
GAAGTGTCGATGATCAA
TGTGTC  
 
 
CTGTGGTAACTTTTCTGA
CACС 
 
 
ATGATCTTGATCTTCATG
GTGCTA 
 
 
GAAAATCCAGTGCAAAG
ACAGAC 
 
